Basile Pache1, Gaëtan-Romain Joliat2, Martin Hübner3, Fabian Grass4, Nicolas Demartines5, Patrice Mathevet6, Chahin Achtari7. 1. Service of Gynecology, Department "Femme-Mère-Enfant", Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland; Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: basile.pache@chuv.ch. 2. Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: gaetan-romain.joliat@chuv.ch. 3. Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: martin.hubner@chuv.ch. 4. Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: fabian.grass@chuv.ch. 5. Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: demartines@chuv.ch. 6. Service of Gynecology, Department "Femme-Mère-Enfant", Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: patrice.mathevet@chuv.ch. 7. Service of Gynecology, Department "Femme-Mère-Enfant", Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: chahin.achtari@chuv.ch.
Abstract
OBJECTIVES: Enhanced recovery after surgery (ERAS) programs has shown clinical benefits in gynecologic surgery. The aim of the present study was to compare costs before and after implementation of an ERAS program for gynecologic surgery. METHODS: Retrospective study comparing perioperative costs between consecutive patient groups undergoing gynecologic surgery (benign, staging or debulking) (I, 2012-13) prior, (II) immediately after, and (III, 2014-16) the three years after ERAS implementation. Preoperative, intraoperative, and postoperative real costs were collected for each patient via hospital administration. A bootstrap independent t-test was used for comparison. RESULTS: Demographics and preoperative characteristics were similar between group I (n = 42), II (n = 51), and III (ERAS I; n = 122, II; n = 134, III; n = 90). Average ERAS-specific costs were $687 per patient. Total mean individual costs per patient were $13'329 (95% confidence interval (CI): 11'301-15'213) and $17'710 (95% CI: 14'452-21'605) in the ERAS and pre-ERAS groups respectively, resulting in net savings of $4'381 (95% CI: 549-8'752, p = 0.043) in favour of ERAS group. Cost savings were explained by lower pre- and postoperative costs (difference: $5'011 95% CI: 1'587-8'998, p = 0.019). Total costs continued to decrease by $2'520 (mean: $15'190, 95% CI: 13'791-16'631) in year 1, by $3'077 (mean: $14'633, 95% CI: 13'378-16'250) and $5'070 (mean: $12'640, 95% CI: 11'460-14'015) (p = 0.03) respectively, in year 2 and 3 after implementation. CONCLUSION: Based on real costs and including specific costs due to ERAS implementation, ERAS program in gynecologic surgery induced significant decrease of overall costs by $4'381 per patient. Total costs continued to decrease in the three years after implementation.
OBJECTIVES: Enhanced recovery after surgery (ERAS) programs has shown clinical benefits in gynecologic surgery. The aim of the present study was to compare costs before and after implementation of an ERAS program for gynecologic surgery. METHODS: Retrospective study comparing perioperative costs between consecutive patient groups undergoing gynecologic surgery (benign, staging or debulking) (I, 2012-13) prior, (II) immediately after, and (III, 2014-16) the three years after ERAS implementation. Preoperative, intraoperative, and postoperative real costs were collected for each patient via hospital administration. A bootstrap independent t-test was used for comparison. RESULTS: Demographics and preoperative characteristics were similar between group I (n = 42), II (n = 51), and III (ERAS I; n = 122, II; n = 134, III; n = 90). Average ERAS-specific costs were $687 per patient. Total mean individual costs per patient were $13'329 (95% confidence interval (CI): 11'301-15'213) and $17'710 (95% CI: 14'452-21'605) in the ERAS and pre-ERAS groups respectively, resulting in net savings of $4'381 (95% CI: 549-8'752, p = 0.043) in favour of ERAS group. Cost savings were explained by lower pre- and postoperative costs (difference: $5'011 95% CI: 1'587-8'998, p = 0.019). Total costs continued to decrease by $2'520 (mean: $15'190, 95% CI: 13'791-16'631) in year 1, by $3'077 (mean: $14'633, 95% CI: 13'378-16'250) and $5'070 (mean: $12'640, 95% CI: 11'460-14'015) (p = 0.03) respectively, in year 2 and 3 after implementation. CONCLUSION: Based on real costs and including specific costs due to ERAS implementation, ERAS program in gynecologic surgery induced significant decrease of overall costs by $4'381 per patient. Total costs continued to decrease in the three years after implementation.
Authors: Karthik C Bassetty; Dhanya Susan Thomas; Ajit Sebastian; Anitha Thomas; Rachel Chandy; Abraham Peedicayil; Vinotha Thomas Journal: J Obstet Gynaecol India Date: 2021-07-01
Authors: Sarah P Huepenbecker; Maria D Iniesta; Andrés Zorrilla-Vaca; Pedro T Ramirez; Katherine E Cain; Micah Vaughn; Juan P Cata; Gabriel E Mena; Javier Lasala; Larissa A Meyer Journal: Gynecol Oncol Date: 2021-08-13 Impact factor: 5.304
Authors: Ross F Harrison; Yao Li; Alexis Guzman; Brandelyn Pitcher; Andrea Rodriguez-Restrepo; Katherine E Cain; Maria D Iniesta; Javier D Lasala; Pedro T Ramirez; Larissa A Meyer Journal: Am J Obstet Gynecol Date: 2019-07-31 Impact factor: 8.661
Authors: Dan B Ellis; Aalok Agarwala; Elena Cavallo; Pam Linov; Michael K Hidrue; Marcela G Del Carmen; Rachel Sisodia Journal: BMC Anesthesiol Date: 2021-02-05 Impact factor: 2.217
Authors: Richard H Parrish; Rachelle Findley; Kevin M Elias; Brian Kramer; Eric G Johnson; Leah Gramlich; Gregg S Nelson Journal: Ann Med Surg (Lond) Date: 2021-12-14